A Novel Frameshift Variant c.1023_1029del (p.Asp342ArgfsTer54) Leading to Extended Incorrect Protein C Termini in HOMER2 Causing Autosomal Dominant Nonsyndromic Hearing Loss
- PMID: 41351289
- DOI: 10.1002/jcla.70137
A Novel Frameshift Variant c.1023_1029del (p.Asp342ArgfsTer54) Leading to Extended Incorrect Protein C Termini in HOMER2 Causing Autosomal Dominant Nonsyndromic Hearing Loss
Abstract
Background: Heterozygous variant in HOMER2 is associated with autosomal dominant nonsyndromic hearing loss (ADNSHL), designated as the locus of DFNA68. Only five pathogenic variants in HOMER2 have been identified to date.
Aims/objectives: The aim of this study is to investigate the molecular etiology of ADNSHL in a four-generation Chinese family.
Material and methods: Whole exome sequencing analysis was conducted to detect the disease-causing variant. Co-segregation analysis was performed using Sanger sequencing.
Results: The family exhibited autosomal dominant, progressive, post-lingual, nonsyndromic sensorineural hearing loss, similar to that observed in previously reported DFNA68 families. Unlike the initially high-frequency hearing loss observed in the previously reported families, the young proband in our study (IV:4, 18 years old) exhibited typical low-frequency hearing loss. A novel frameshift variant, c.1023_1029del (p.Asp342ArgfsTer54), in HOMER2 was identified, which co-segregated with the hearing loss phenotype in the family. The variant deletes 7 nucleotides, leading to an extended incorrect protein C terminus. Based on the American College of Medical Genetics and Genomics guidelines, the variant c.1023_1029del (p.Asp342ArgfsTer54) is classified as likely pathogenic.
Conclusions and significance: These findings may help expand the spectrum of pathogenic variants of the HOMER2 gene and provide a molecular interpretation for these patients with ADNSHL.
Keywords: HOMER2; ADNSHL; DFNA68; frameshift variant; hearing loss.
© 2025 The Author(s). Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
References
-
- D. R. Lenz and K. B. Avraham, “Hereditary Hearing Loss: From Human Mutation to Mechanism,” Hearing Research 281, no. 1–2 (2011): 3–10, https://doi.org/10.1016/j.heares.2011.05.021.
-
- H. Azaiez, A. R. Decker, K. T. Booth, et al., “HOMER2, a Stereociliary Scaffolding Protein, Is Essential for Normal Hearing in Humans and Mice,” PLoS Genetics 11, no. 3 (2015): e1005137, https://doi.org/10.1371/journal.pgen.1005137.
-
- Y. M. Yang, J. Lee, H. Jo, et al., “Homer2 Protein Regulates Plasma Membrane ca(2) (+)‐ATPase‐Mediated ca(2) (+) Signaling in Mouse Parotid Gland Acinar Cells,” Journal of Biological Chemistry 289, no. 5 (2014): 24971–24979, https://doi.org/10.1074/jbc.M114.577221.
-
- Y. Shiraishi‐Yamaguchi, Y. Sato, R. Sakai, et al., “Interaction of Cupidin/Homer2 With Two Actin Cytoskeletal Regulators, Cdc42 Small GTPase and Drebrin, in Dendritic Spines,” BMC Neuroscience 10, no. 24 (2009): 25, https://doi.org/10.1186/1471‐2202‐10‐25.
-
- W. P. Gilks, E. H. Allott, G. Donohoe, et al., “Replicated Genetic Evidence Supports a Role for HOMER2 in Schizophrenia,” Neuroscience Letters 468, no. 3 (2010): 229–233, https://doi.org/10.1016/j.neulet.2009.11.003.
Grants and funding
LinkOut - more resources
Full Text Sources
